Mel-Mont Medical

Doral, United States Founded: 2014 • Age: 12 yrs
Molecular screening devices for early infectious disease detection are developed.
Annual revenue - Latest available
Total funding $10.2M 3 rounds
Employees - Tracked headcount
Investors - Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About Mel-Mont Medical

Mel-Mont Medical is a company based in Doral (United States) founded in 2014 by Liliana Montes and Frank Melendez. Mel-Mont Medical has raised $10.15 million across 3 funding rounds. Mel-Mont Medical operates in a competitive market with competitors including OpGen, Day Zero Diagnostics, Clear Labs, Karius and Seegene Technologies, among others.

  • Headquarter Doral, United States
  • Founders Liliana Montes, Frank Melendez
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $10.15 M (USD)

    in 3 rounds

  • Latest Funding Round
    $250 K (USD), Series A

    Dec 11, 2025

  • Investors
    Not available
  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Mel-Mont Medical

Mel-Mont Medical has successfully raised a total of $10.15M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $250 thousand completed in December 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investments & Acquisitions by Mel-Mont Medical

Investments
Premium access

Investment portfolio details for Mel-Mont Medical

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Mel-Mont Medical

Premium access

Detailed financials for Mel-Mont Medical

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Mel-Mont Medical Comparisons

Mel-Mont Medical Primary company
Description
Molecular screening devices for early infectious disease det...
Location
Doral, United States
Founded Year
2014
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Mel-Mont Medical

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Mel-Mont Medical

Mel-Mont Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as OpGen, Day Zero Diagnostics, Clear Labs, Karius and Seegene Technologies, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Developer of diagnostics and bioinformatics platforms for providers
Locked Locked Locked
Genome sequencing diagnostics for infectious diseases are developed.
Locked Locked Locked
Food safety technologies are provided for pathogen identification.
Locked Locked Locked
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
Locked Locked Locked
Developer of molecular diagnostic kits to detect infectious and genetic diseases
Locked Locked Locked
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
Premium access

Detailed competitors of Mel-Mont Medical

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Mel-Mont Medical

Premium access

Complete news archive for Mel-Mont Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mel-Mont Medical

Mel-Mont Medical was founded in 2014 and raised its 1st funding round 6 years after it was founded.

Mel-Mont Medical is headquartered in Doral, United States. It is registered at Doral, Florida, United States.

Frank Melendez is the current CEO of Mel-Mont Medical. They have also founded this company.

Mel-Mont Medical is a funded company, having raised a total of $10.15M across 3 funding rounds to date.

Developer of molecular screening devices for the early detection of infectious diseases. The company develops a diversified portfolio of proprietary technologies and medical devices for the early identification of DNA and RNA virus-related pathologies. The product portfolio includes XytoTest and Anal test for cervical cancer, and HR-HPV DNA detection. Also, offers in-vitro diagnostic tests for the detection of HPV infections.

Mel-Mont Medical's top competitors include Clear Labs, Day Zero Diagnostics and Karius.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available